Bedrijfsoverzicht
Quipt Home Medical Corp. is a specialized entity dedicated to the distribution of durable medical equipment and supplies throughout the United States market. The company provides a comprehensive range of solutions including nebulizers, invasive ventilation systems, sleep apnea and PAP treatment devices, home ventilation units, and daily ambulatory AI equipment. Operating within the healthcare sector and specifically the medical distribution industry, the firm functions as a critical supply chain link for essential medical technologies used in home care settings. With a market capitalization of $162.30M, annual revenue of $264.97M, and an employee base of 1500, the company demonstrates significant operational scale within its niche. These financial dimensions indicate that Quipt Home Medical Corp. has established a substantial footprint in the medical equipment distribution landscape, positioning it as a notable player capable of influencing supply dynamics in the home medical care sector.
Financiële gezondheid
Quipt Home Medical Corp. reported total revenue of $264.97M over the trailing twelve months, yet recorded a net income loss of $-10,670,000, while maintaining a robust EBITDA of $43.58M. The substantial gap between the positive EBITDA of $43.58M and the negative net income of $-10,670,000 reveals a cost structure heavily impacted by non-operating expenses, such as interest costs or tax provisions, which erode bottom-line profitability despite strong operational earnings. The company generated free cash flow of $44.54M, a figure that underscores significant financial flexibility allowing for potential capital allocation strategies despite the reported accounting losses. This positive free cash flow is particularly notable given that the company holds $10.54M in cash against total debt obligations of $115.63M. The balance sheet reflects a highly leveraged position, evidenced by a debt-to-equity ratio of 102.33, which suggests a capital structure weighted heavily toward debt financing. Liquidity constraints are visible with a current ratio of 1.04, indicating that the company's current assets barely exceed its current liabilities, a metric that requires careful monitoring for short-term solvency. Furthermore, the return metrics show a return on equity of -9.3% and a return on assets of -0.8%, which collectively indicate that management has not yet generated positive returns on the capital invested in the business during the current reporting period.
Waarderingsbeoordeling
The valuation metrics present a stark contrast between the trailing and forward perspectives, as the trailing P/E ratio is listed as N/A due to the net income loss, while the forward P/E is calculated at 182.50. This extreme disparity between the unavailable trailing multiple and the high forward multiple implies that the market prices in a significant turnaround in expected earnings trajectory or assumes that future earnings will be generated from a base that is currently negative. The price-to-book ratio stands at 1.59, suggesting that the market is valuing the company at a premium of 59% over its book value, which can indicate confidence in intangible assets or future growth potential despite current profitability challenges. Alternative valuation measures provide additional context, with a price-to-sales ratio of 0.61 and an EV/EBITDA of 6.41, suggesting the company trades at a discount relative to sales but maintains a reasonable multiple against earnings before interest, taxes, depreciation, and amortization. In terms of trading range, the stock has a 52-week high of $3.65 and a 52-week low of $1.35, providing a wide band of volatility within which the current price fluctuates. The beta value of 0.49 indicates that the stock's price volatility is less than half that of the broader market, implying lower systemic risk compared to the general equity market index.
Growth & Income
Quipt Home Medical Corp. is experiencing rapid expansion with revenue growth of 32.0% year-over-year, whereas earnings growth is listed as N/A due to the current net loss position. Since earnings are negative, they cannot grow faster or slower than revenue in the traditional sense, but the trajectory suggests that revenue expansion is currently outpacing any ability to generate net profit, a common characteristic in scaling distribution businesses. The company does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which indicates that the firm retains all of its earnings to fund operations, debt servicing, and growth initiatives rather than distributing cash to shareholders. This reinvestment strategy is typical for companies in high-growth phases or those managing significant leverage, where capital preservation and operational scaling take precedence over income distribution. The overall growth and income profile is characterized by aggressive revenue expansion supported by strong free cash flow generation, but currently lacking in dividend income and bottom-line profitability.